Cargando…

Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial

PURPOSE: IMPORT LOW demonstrated noninferiority of partial-breast and reduced-dose radiotherapy versus whole-breast radiotherapy for local relapse and similar or reduced toxicity at 5 years. Comprehensive patient-reported outcome measures collected at serial time points are now reported. PATIENTS AN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhattacharya, Indrani S., Haviland, Joanne S., Kirby, Anna M., Kirwan, Cliona C., Hopwood, Penelope, Yarnold, John R., Bliss, Judith M., Coles, Charlotte E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2019
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357225/ https://www.ncbi.nlm.nih.gov/pubmed/30532984 http://dx.doi.org/10.1200/JCO.18.00982

Ejemplares similares

Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial
por: Bhattacharya, Indrani S., et al.
Publicado: (2019)

Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial
por: Bhattacharya, Indrani S., et al.
Publicado: (2019)

Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design
por: Bhattacharya, Indrani S., et al.
Publicado: (2021)

Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis
por: Glynn, David, et al.
Publicado: (2022)

Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)
por: Staffurth, John N., et al.
Publicado: (2021)

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
por: Coles, Charlotte E, et al.
Publicado: (2017)

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
por: Murray Brunt, Adrian, et al.
Publicado: (2020)

Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials
por: Haviland, Joanne S, et al.
Publicado: (2018)

Women's Free-text Comments on their Quality of Life: An Exploratory Analysis from the UK Standardisation of Breast Radiotherapy (START) Trials for Early Breast Cancer
por: Mills, J., et al.
Publicado: (2018)

Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer
por: Wilkins, Anna, et al.
Publicado: (2018)

PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)
por: Syndikus, Isabel, et al.
Publicado: (2020)

Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?
por: Bhattacharya, I.S., et al.
Publicado: (2018)

Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001)
por: Hall, E., et al.
Publicado: (2014)

Consequences of COVID-19 for cancer care — a CRUK perspective
por: Greenwood, Emma, et al.
Publicado: (2020)

A multicentre study of the evidence for customized margins in photon breast boost radiotherapy
por: Harris, Emma J, et al.
Publicado: (2016)

EP06.01-003 Impact of COVID-19 on Lung Cancer Patients; The Patients’ Perspective
por: Samnani, S., et al.
Publicado: (2022)

Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK – A16037)
por: Banerjee, Susana, et al.
Publicado: (2020)

Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)
por: Nutting, Christopher M., et al.
Publicado: (2018)

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
por: Bartlett, Frederick R., et al.
Publicado: (2014)

Can routine data be used to support cancer clinical trials? A historical baseline on which to build: retrospective linkage of data from the TACT (CRUK 01/001) breast cancer trial and the National Cancer Data Repository
por: Kilburn, Lucy Suzanne, et al.
Publicado: (2017)

Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy
por: Westbury, Charlotte B, et al.
Publicado: (2014)

The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)
por: Choudhury, Ananya, et al.
Publicado: (2017)

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
por: Ring, Alistair, et al.
Publicado: (2023)

Metal-Semiconductor AsSb-Al(0.6)Ga(0.4)As(0.97)Sb(0.03) Metamaterial
por: Bert, Nikolay, et al.
Publicado: (2022)

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer
por: Brunt, Adrian Murray, et al.
Publicado: (2020)

Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)
por: Bliss, Judith M., et al.
Publicado: (2023)

Changes in radiotherapy fractionation—breast cancer
por: Yarnold, John
Publicado: (2019)

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial
por: Ellis, Paul, et al.
Publicado: (2009)

Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies
por: Batten, Leona M., et al.
Publicado: (2018)

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial
por: Brunt, A. Murray, et al.
Publicado: (2016)

Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)
por: Nicholson, S, et al.
Publicado: (2013)

AB003. Benefits of proton radiotherapy in thymic epithelial tumors using the model-based approach
por: Peeters, Stephanie T. H., et al.
Publicado: (2022)

Top Physics at ATLAS 003
por: Stavropoulos, G D
Publicado: (2004)

Optimization and partial characterization of culture conditions for the production of alkaline protease from Bacillus licheniformis P003
por: Sarker, Palash Kumar, et al.
Publicado: (2013)

Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011)
por: Paramasivan, Sangeetha, et al.
Publicado: (2011)

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial
por: Cameron, David, et al.
Publicado: (2017)

Optimized electrochemical performance of Ni rich LiNi(0.91)Co(0.06)Mn(0.03)O(2) cathodes for high-energy lithium ion batteries
por: Lee, Seung-Hwan, et al.
Publicado: (2019)

Improved electrochemical properties of LiNi(0.91)Co(0.06)Mn(0.03)O(2) cathode material via Li-reactive coating with metal phosphates
por: Min, Kyoungmin, et al.
Publicado: (2017)

OR6-003 – Prospective evaluation of PFAPA patients
por: Bosio, I, et al.
Publicado: (2013)

P01-003 – Bleeding disorder in FMF
por: Karadag, O, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pl6bl4jhbbmt0kvjbsb5floe5c